Further identification and characterization of mechanisms directly connecting ABCG2 to CS-associated apoptosis and signaling are mandatory for establishing a new therapeutic strategy, selectively targeting and eliminating resistant cancer cells. The gene discussed is ABCG2; the disease is cancer.